109 related articles for article (PubMed ID: 15069543)
1. Regulatory roles of N-glycosylation of immunoglobulin M in CD40-CD40L-mediated cell survival of human diffuse large B cell lymphoma.
Suzuki O; Nozawa Y; Abe M
Oncol Rep; 2004 May; 11(5):1031-9. PubMed ID: 15069543
[TBL] [Abstract][Full Text] [Related]
2. Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma.
Suzuki O; Nozawa Y; Abe M
Oncol Rep; 2005 Jan; 13(1):109-14. PubMed ID: 15583810
[TBL] [Abstract][Full Text] [Related]
3. Regulatory roles of altered N- and O-glycosylation of CD45 in galectin-1-induced cell death in human diffuse large B cell lymphoma.
Suzuki O; Nozawa Y; Abe M
Int J Oncol; 2005 Apr; 26(4):1063-8. PubMed ID: 15754003
[TBL] [Abstract][Full Text] [Related]
4. The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1.
Suzuki O; Nozawa Y; Abe M
Int J Oncol; 2006 Jan; 28(1):155-60. PubMed ID: 16327992
[TBL] [Abstract][Full Text] [Related]
5. Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma.
Suzuki O; Abe M
Oncol Rep; 2008 Mar; 19(3):743-8. PubMed ID: 18288410
[TBL] [Abstract][Full Text] [Related]
6. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
Schauer SL; Bellas RE; Sonenshein GE
J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
[TBL] [Abstract][Full Text] [Related]
7. Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking.
Sumimoto S; Heike T; Kanazashi S; Shintaku N; Jung EY; Hata D; Katamura K; Mayumi M
J Immunol; 1994 Sep; 153(6):2488-96. PubMed ID: 7521364
[TBL] [Abstract][Full Text] [Related]
8. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
9. Extracellular HSP70 blocks CD40L-induced apoptosis and tubular formation in endothelial cells.
Futagami S; Hiratsuka T; Shindo T; Hamamoto T; Horie A; Ueki N; Kusunoki M; Gudis K; Miyake K; Tsukui T; Sakamoto C
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S222-8. PubMed ID: 19120902
[TBL] [Abstract][Full Text] [Related]
10. Constitutive expression of functional CD40 on mouse renal cancer cells: induction of Fas and Fas-mediated killing by CD40L.
Lee JK; Seki N; Sayers TJ; Subleski J; Gruys EM; Murphy WJ; Wiltrout RH
Cell Immunol; 2005 Jun; 235(2):145-52. PubMed ID: 16213477
[TBL] [Abstract][Full Text] [Related]
11. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction.
Holder MJ; Wang H; Milner AE; Casamayor M; Armitage R; Spriggs MK; Fanslow WC; MacLennan IC; Gregory CD; Gordon J
Eur J Immunol; 1993 Sep; 23(9):2368-71. PubMed ID: 8103750
[TBL] [Abstract][Full Text] [Related]
12. Regulatory roles of cell surface sialylation in susceptibility to sphingomyelinase in human diffuse large B cell lymphoma.
Suzuki O; Nozawa Y; Abe M
Int J Oncol; 2005 Jul; 27(1):209-14. PubMed ID: 15942662
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
[TBL] [Abstract][Full Text] [Related]
14. Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation.
Mueller CG; Boix C; Kwan WH; Daussy C; Fournier E; Fridman WH; Molina TJ
J Leukoc Biol; 2007 Sep; 82(3):567-75. PubMed ID: 17575267
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin.
Gordon J; Challa A; Levens JM; Gregory CD; Williams JM; Armitage RJ; Cook JP; Roberts LM; Lord JM
Cell Death Differ; 2000 Sep; 7(9):785-94. PubMed ID: 11042673
[TBL] [Abstract][Full Text] [Related]
16. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway.
Carey GB; Semenova E; Qi X; Keegan AD
Cell Res; 2007 Nov; 17(11):942-55. PubMed ID: 17968425
[TBL] [Abstract][Full Text] [Related]
17. CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.
Burington B; Yue P; Shi X; Advani R; Lau JT; Tan J; Stinson S; Stinson J; Januario T; de Vos S; Ansell S; Forero-Torres A; Fedorowicz G; Yang TT; Elkins K; Du C; Mohan S; Yu N; Modrusan Z; Seshagiri S; Yu SF; Pandita A; Koeppen H; French D; Polson AG; Offringa R; Whiting N; Ebens A; Dornan D
Sci Transl Med; 2011 Mar; 3(74):74ra22. PubMed ID: 21411738
[TBL] [Abstract][Full Text] [Related]
18. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
Cillessen SA; Meijer CJ; Ossenkoppele GJ; Castricum KC; Westra AH; Niesten P; Muris JJ; Nijdam HF; van der Hem KG; Flens M; Hooijberg E; Oudejans JJ
Br J Haematol; 2006 Aug; 134(3):283-93. PubMed ID: 16848771
[TBL] [Abstract][Full Text] [Related]
19. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
Law CL; Gordon KA; Collier J; Klussman K; McEarchern JA; Cerveny CG; Mixan BJ; Lee WP; Lin Z; Valdez P; Wahl AF; Grewal IS
Cancer Res; 2005 Sep; 65(18):8331-8. PubMed ID: 16166310
[TBL] [Abstract][Full Text] [Related]
20. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
Volmar CH; Ait-Ghezala G; Frieling J; Weeks OI; Mullan MJ
Exp Cell Res; 2009 Aug; 315(13):2265-74. PubMed ID: 19422822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
